What is a transdermal patch (TP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Transdermal Patch?

A transdermal patch (TP) is an adhesive drug delivery device applied to the skin that releases medication at a controlled rate for systemic absorption through the skin and into the bloodstream, bypassing gastrointestinal metabolism and providing sustained therapeutic drug levels. 1, 2

Core Mechanism and Design

  • Transdermal patches are non-invasive dosage forms designed to deliver a specific dose of medication through the skin barrier into systemic circulation 1, 3
  • The patch consists of an adhesive component that is critical to safety, efficacy, and quality—ensuring the device remains in contact with skin for the intended duration 4
  • Drug delivery occurs through skin penetration, avoiding first-pass hepatic metabolism that occurs with oral medications 1, 2

Key Advantages Over Other Routes

  • Avoids gastrointestinal issues: Eliminates problems with enzymatic digestion, drug hydrolysis in acidic stomach environment, and GI irritation 1, 3
  • Stable drug levels: Provides more consistent serum concentrations compared to oral or injectable routes that produce peaks and troughs 5
  • Patient convenience: Reduces dosing frequency and improves adherence compared to multiple daily oral doses 3
  • Bypasses liver metabolism: Drug enters systemic circulation directly without initial hepatic processing 2

Common Medical Applications

Transdermal patches are FDA-approved and widely used for multiple therapeutic areas:

  • Pain management: Fentanyl patches for chronic pain (25 μg/h dosing applied 12-14 hours before surgery in perioperative settings) 6
  • Hormone replacement: Testosterone patches and contraceptive patches (estrogen/progestin combinations) 6
  • Cardiovascular: Nitroglycerin for angina pectoris 1, 3
  • Smoking cessation: Nicotine patches 1
  • Hypertension: Clonidine patches 1

Important Clinical Considerations

  • Adhesion is critical: The FDA Drug Quality Reporting System has received numerous reports of "adhesion lacking" for transdermal systems—proper skin preparation and application site selection are essential 4
  • Skin reactions: Local adverse effects include contact dermatitis, hyperpigmentation, discharge, and discomfort at application sites 6
  • Transfer risk: Gel and patch formulations can inadvertently transfer medication to other individuals through prolonged skin contact 5
  • Application sites: Patches are typically placed on non-sun-exposed areas such as the abdomen, upper torso, upper outer arm, or buttocks 6

Monitoring and Safety

  • For hormone patches (testosterone), peak serum levels occur 6-8 hours after patch application, and levels can be measured at any time once steady state is achieved 5
  • Transdermal fentanyl reaches constant concentrations without evidence of respiratory depression when properly dosed 6
  • Patches should remain undisturbed for the prescribed duration (typically 24-72 hours depending on formulation) to ensure adequate drug delivery 6

References

Research

Delivering drugs by the transdermal route: review and comment.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2008

Research

Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2006

Guideline

Comparative Efficacy of Testosterone Replacement Therapy Formulations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.